NanoVibronix, Inc. (NAOV)
After hours:
| Previous Close | 0.5199 |
| Open | 0.5400 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.5200 - 0.5680 |
| 52 Week Range | 0.4580 - 1.5500 |
| Volume | |
| Avg. Volume | 124,115 |
| Market Cap | 1.52M |
| Beta (5Y Monthly) | 1.50 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2900 |
| Earnings Date | Nov 11, 2024 - Nov 15, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany
ELMSFORD, N.Y., October 09, 2024--NanoVibronix, Inc., (NASDAQ: NAOV) (the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave ("SAW") Portable Ultrasonic Therapeutic Devices, today announced it has signed a non-binding term sheet for a license and supply agreement with APOGEPHA Arzneimittel GmbH ("APOGEPHA"), a German pharmaceutical company, which specializes in the development, marketing, sales and distribution of urology product
- Business Wire
NanoVibronix Signs Letter of Intent with Potential New Distributor
ELMSFORD, N.Y., September 23, 2024--NanoVibronix, Inc., (NASDAQ: NAOV) (the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed a letter of intent with Medici Medical LTD ("Medici"), a leading distributor of medical products in the Israeli healthcare market, to explore the opportunities for distribution of the Company’s UroShield device in Israel.
